Advice
Development of this evidence summary
Development of this evidence summary
This evidence summary was developed for NICE by Bazian Ltd. The interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.
Peer reviewers and contributors
Emma Chambers, Public Involvement Programme, NICE
Satkartar Jandu, Merck Serono (UK)